Alpha synuclein promoter and risk of Parkinson's disease: Microsatellite and allelic size variability

Neuroscience Letters

Volumn 336, Issue 1, 2003, Pages 70-72

  Tan, Eng King ^a   Tan, Christopher ^a   Shen, Hui ^a   Chai, Anthea ^a   Lum, Sau Ying ^a   Teoh, Mei Lin ^a   Yih, Yuan ^b   Wong, Meng Cheong ^a   Zhao, Yi ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b Singapore Health Services   (Singapore)

Author keywords

Alpha synuclein; Microsatellite; Parkinson's disease; Polymorphism

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGE; AGED; ALLELE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; FEMALE; GENDER; GENE FREQUENCY; GENE INTERACTION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HEALTH STATUS; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; RACE; RISK ASSESSMENT;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALPHA-SYNUCLEIN; CASE-CONTROL STUDIES; DINUCLEOTIDE REPEATS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS; SYNUCLEINS;

EID: 0037426704     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01178-3     Document Type: Article

References (15)

1. Bird T.D., Jarvik G.P., Wood N.W. Genetic association studies: genes in search of diseases. Neurology. 57:2001;1153-1154.
2. Chiba-Falek O., Nussbaum R.L. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum. Mol. Genet. 10:2001;3101-3109.
3. Farrer M., Maraganore D.M., Lockhart P., Singleton A., Lesnick T.G., de Andrade M., West A., de Silva R., Hardy J., Hernandez D. alpha-Synuclein gene haplotypes are associated with Parkinson's disease. Hum. Mol. Genet. 10:2001;1847-1851.
4. Freely associating. Nat. Genet. 22 (1999) 1-2 (editorial).
5. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry. 55:1992;181-184.
6. Izumi Y., Morino H., Oda M., Maruyama H., Udaka F., Kameyama M., Nakamura S., Kawakami H. Genetic studies in Parkinson's disease with an alpha-synuclein/NACP gene polymorphism in Japan. Neurosci. Lett. 300:2001;125-127.
7. Khan N., Graham E., Dixon P., Morris C., Mander A., Clayton D., Vaughan J., Quinn N., Lees A., Daniel S., Wood N., de Silva R. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype. Ann. Neurol. 49:2001;665-668.
8. Krüger R., Vieira-Saecker A.M.M., Kuhn W., Berg D., Muller T., Kuhnl N., Fuchs G.A., Storch A., Hungs M., Woitalla D., Przuntek H., Epplen J.T., Schols L., Riess O. Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann. Neurol. 45:1999;611-617.
9. Parsian A., Racette B., Zhang Z.H., Chakraverty S., Rundle M., Goate A., Perlmutter J.S. Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease. Neurology. 51:1998;1757-1759.
10. Polymeropoulos M.H., Laavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
11. Tan E.K., Chai A., Zhao Y., Lum S.Y., Fook-Chong S.M.C., Teoh M.L., Yih Y., Pavanni R., Wong M.C. Mitochondrial complex I polymorphism and cigarette smoking in Parkinson's disease. Neurology. 59:2002;1288-1289.
12. Tan E.K., Khajavi M., Thornby J.I., Nagamitsu S., Jankovic J., Ashizawa T. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology. 55:2000;533-538.
13. Tan E.K., Matsuura T., Nagamitsu S., Khajavi M., Jankovic J., Ashizawa T. Polymorphism of NACP-Rep1 in Parkinson's disease: an etiologic link with essential tremor? Neurology. 54:2000;1195-1198.
14. Wang W.W., Khajavi M., Patel B.J., Beach J., Jankovic J., Ashizawa T. The G209A mutation in the alpha-synuclein gene is not detected in familial cases of Parkinson's disease in non-Greek and/or Italian populations. Arch. Neurol. 55:1998;1521-1523.
15. Xia Y., Rohan de Silva H.A., Rosi B.L., Yamaoka L.H., Rimmler J.B., Pericak-Vance M.A., Roses A.D., Chen X., Masliah E., DeTeresa R., Iwai A., Sundsmo M., Thomas R.G., Hofstetter C.R., Gregory E., Hansen L.A., Katzman R., Thal L.J., Saitoh T. Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism. Ann. Neurol. 40:1996;207-215.